ABT-737 is a rationally designed small molecule that binds with high affinity to Bcl-2 and Bcl-xL and antagonizes their anti-apoptotic function, thereby inducing apoptosis in many cancer cell types [14,15]. Here, BCL2L1 is linked to cancer.